It has demonstrated that CML patients with type 2 diabetes have markedly elevated levels of adiponectin, implicating a mechanism for improved insulin sensitivity in the peripheral tissues [9], [20]. The gene discussed is ADIPOQ; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.